Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion type Assertion NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_head.
- NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion description "[We found a two-fold increased risk of T-cell lymphoma among those possessing the NAT1*10 genotype compared to those with other NAT1 genotypes; including an OR of 2.0 (95% CI: 1.0-2.4) for those heterozygous or homozygous for NAT1*10 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_provenance.
- NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion evidence source_evidence_literature NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_provenance.
- NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion SIO_000772 19809881 NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_provenance.
- NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion wasDerivedFrom befree-20150227 NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_provenance.
- NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_assertion wasGeneratedBy ECO_0000203 NP217330.RAJAFG63D3fVfgKw6wwZm8clM_4QEnW5EFkn6rKHNiZCM130_provenance.